NewKerala.com

Key ALS Protein TDP43 Controls DNA Repair, Links Dementia to Cancer

Researchers have discovered that the protein TDP43, associated with ALS and dementia, is a critical regulator of the DNA mismatch repair system. Abnormal levels of TDP43 cause excessive repair activity that can damage neurons and destabilize the genome, potentially increasing cancer risk. Analysis of cancer databases shows higher TDP43 levels correlate with greater mutation loads in tumors. The findings suggest controlling this DNA repair pathway could open new therapeutic strategies for both neurodegenerative diseases and cancer.

Key Points: TDP43 Protein Links DNA Repair to ALS, Dementia, and Cancer

  • TDP43 regulates DNA mismatch repair genes
  • Abnormal levels destabilize genome and harm neurons
  • High TDP43 linked to more tumor mutations
  • Discovery reshapes understanding of ALS, dementia, and cancer
  • Controlling repair may offer new therapy
2 min read

Scientists discover ALS protein that links DNA repair to cancer and dementia: Study

Scientists discover protein TDP43 regulates DNA mismatch repair, connecting neurodegenerative diseases like ALS to increased cancer risk.

"This puts it at the intersection of two of the most important disease categories of our time: neurodegeneration and cancer. - Muralidhar L Hegde"

Washington DC, March 16

Researchers at Houston Methodist have discovered that a protein tied to neurodegenerative conditions such as dementia and amyotrophic lateral sclerosis also helps control a critical DNA repair process, according to a press release issued by ScienceDaily.

This repair system, known as DNA mismatch repair, corrects mistakes that occur when cells copy genetic material.

The discovery suggests that the protein may influence both brain diseases and cancer, potentially reshaping how scientists think about these major health conditions.

The study, published in Nucleic Acids Research, shows that the protein 'TDP43' regulates genes responsible for fixing DNA errors.

According to the release, when levels of this protein drop too low or rise too high, those repair genes become overly active. Instead of protecting cells, the heightened repair activity can harm neurons and destabilise the genome, which may increase the risk of cancer.

"DNA repair is one of the most fundamental processes in biology," said lead investigator Muralidhar L Hegde, PhD, professor of neurosurgery at the Houston Methodist Research Institute's Centre for Neuroregeneration.

"What we found is that TDP43 is not just another RNA-binding protein involved in splicing, but a critical regulator of mismatch repair machinery. That has major implications for diseases like ALS and frontotemporal dementia (FTD) where this protein goes awry," added Hegde.

The researchers also uncovered evidence linking the protein to cancer. By analysing large cancer databases, the team found that higher amounts of TDP43 were associated with greater numbers of mutations in tumours.

"This tells us that the biology of this protein is broader than just ALS or FTD," Hegde said. "In cancers, this protein appears to be upregulated and linked to increased mutation load. That puts it at the intersection of two of the most important disease categories of our time: neurodegeneration and cancer," added Hedge, as per the release.

The scientists say the findings may also point toward new treatment approaches. In laboratory models, reducing the excessive DNA repair activity caused by abnormal TDP43 helped partially reverse cellular damage.

Hegde said that controlling DNA mismatch repair may offer a therapeutic strategy.

- ANI

Share this article:

Reader Comments

P
Priya S
My grandfather suffered from dementia. Reading about discoveries like this gives me hope for future generations. It's incredible how one protein can connect brain health and cancer. More funding should go to this kind of fundamental science. 🙏
M
Michael C
As someone in the biotech field, the therapeutic angle is the most exciting part. "Controlling" DNA mismatch repair is a delicate balance, but if they can find a drug target, it would be massive. The link to increased tumor mutations is a crucial finding.
S
Shreya B
A respectful critique: The article is very promising, but it's based on a press release and lab models. We've seen many "breakthroughs" that don't translate to human treatments for years, if ever. Let's temper excitement with patience until clinical trials.
R
Rohit P
Wow! Connecting dementia and cancer through a single protein? Our bodies are so complex. This is why basic research is important, even if it doesn't show immediate results. Jai Vigyan!
N
Nisha Z
The part about the protein level being "too low OR too high" causing problems is key. It's not just about presence or absence, but precise regulation. Nature's balance is everything. Hope this leads to better diagnostics.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50